Labsystems Diagnostics Oy

Labsystems Diagnostics Oy is a specialized developer, manufacturer, and marketer of high-quality diagnostic solutions. Their core focus areas include newborn screening, infectious diseases, and clinical biochemistry, offering a comprehensive product portfolio. This includes advanced enzyme immunoassays, precise molecular tests, and convenient point-of-care tests designed for clinical laboratories, home use, and physician offices worldwide. The company is particularly recognized as a pioneer and leader in newborn screening technology, providing essential instruments and reagents critical for effective infant health checks. With a legacy spanning nearly 40 years, Labsystems Diagnostics Oy is committed to innovating medical technology products and services to enhance global healthcare accessibility.

Operating with a dedicated team of 500 - 1,000 employees, Labsystems Diagnostics Oy leverages extensive experience to drive innovation in the medical technology sector. Their commitment extends to developing cutting-edge solutions that meet stringent quality and regulatory specifications. The company's strategic vision involves continuous advancement in diagnostic capabilities, aiming to address evolving healthcare needs and improve patient outcomes across diverse medical fields. Meet Labsystems Diagnostics Oy's team to understand the expertise driving these advancements.

With a revenue of $17.6M, Labsystems Diagnostics Oy maintains a significant presence in the global diagnostics market. Their product range, including IVD kits and laboratory testing solutions, supports healthcare providers in delivering accurate and timely diagnoses. The company's dedication to quality and innovation positions them as a key player in advancing diagnostic science and making essential health screenings more accessible internationally. Their two locations underscore their operational footprint.